7,967 followers
Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies https://t.co/lUmyJhfr3K
Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies https://t.co/lUmyJhfr3K
New research: Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies: Currently, immune checkpoint inhibitors (ICIs) are widely considered the standard initial treatment for advanced… #oncology ht